Beth Israel Deaconess Medical Center (BIDMC) and Deerfield Management, a healthcare investment firm, announce a research collaboration to accelerate discovery of novel therapeutics. Deerfield will provide up to $130 million along with additional scientific and operational support to this collaboration to advance BIDMC research that has the potential to transform patient care over the next decade.
“We are honored to collaborate with Deerfield Management to help provide our investigators with the infrastructure and support necessary to create transformative medicines,” said Gyongyi Szabo, MD, PhD, chief academic officer of BIDMC and Beth Israel Lahey Health. “Research is an essential component of clinical care. Aligning with Deerfield will bolster the outstanding work by BIDMC investigators, translating the discoveries from bench to bedside at a more rapid pace. The collaboration will provide a seamless mechanism to advance discoveries fueled by the recently launched BIDMC Translational Research Hubs.”
